Thymidylate synthetase allelic imbalance in clear cell renal carcinoma

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1195-1200

  Colavito, Davide ^a   Cartei, Giuseppe ^b,d   Dal Bianco, Massimo ^c   Stecca, Anna ^a   Zustovich, Fable ^b   Dalle Carbonare, Maurizio ^a   Ragazzi, Eugenio ^e   Farina, Miriam ^b   Colombrino, Eva ^b   Leon, Alberta ^a  

^a Research and Innovation SpA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c S ANTONIO HOSPITAL   (Italy)

^d International Academy Environmental Sciences (IAES)   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

Author keywords

Allelic imbalance; Microsatellite analysis; Renal cell carcinoma; Thymidylate synthetase

Indexed keywords

DNA FRAGMENT; FLUOROURACIL; THYMIDYLATE SYNTHASE;

5' UNTRANSLATED REGION; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CHROMOSOME 18P; CHROMOSOME BAND; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; DNA EXTRACTION; FEMALE; GENE FREQUENCY; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; KIDNEY CARCINOMA; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TANDEM REPEAT; TREATMENT RESPONSE; VARIABLE NUMBER OF TANDEM REPEAT;

5' UNTRANSLATED REGIONS; AGED; ALLELIC IMBALANCE; CARCINOMA, RENAL CELL; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; THYMIDYLATE SYNTHASE;

EID: 69049117206     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0986-9     Document Type: Article

References (30)

1. JA Garcia BI Rini 2007 Recent progress in the management of advanced renal cell carcinoma CA Cancer J Clin 57 112 125
2. A Yagoda B Abi-Rached D Petrylak 1995 Chemotherapy for advanced renal-cell carcinoma: 1983-1993 Semin Oncol 22 42 60
3. A Bamias Ch Deliveliotis G Fountzilas, et al. 2004 Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary tract: a study by the Hellenic Cooperative Oncology Group J Clin Oncol 22 2150 2154
4. K Fizazi F Rolland C Chevreau, et al. 2003 A phase II study of irinotecan in patients with advanced renal cell carcinoma Cancer 98 61 65
5. AN Vis A van der Gaast BW van Rhijn, et al. 2002 A phase II trial of methotrexate-human serum albumin (MTX-HSA) in patients with metastatic renal cell carcinoma who progressed under immunotherapy Cancer Chemother Pharmacol 49 342 345
6. F Zustovich G Cartei M Dal Bianco, et al. 2006 A phase II study of gemcitabine and immunotherapy in renal cancer: preliminary results and review of the literature Ann Oncol 17 Suppl 5 133 136
7. AA Adjei 2002 Pemetrexed in the treatment of selected solid tumors Semin Oncol 29 50 53
8. S Negrier A Caty T Lesimple, et al. 2000 Treatment of patients with metastatic renal carcinoma with a combination of subcutaneous interleukin-2 and interferon alfa with or without fluorouracil. Groupe Francais d'Immunotherapie, Federation Nationale des Centres de Lutte Contre le Cancer J Clin Oncol 18 4009 4015
9. MJ Allen M Vaughan A Webb, et al. 2000 Protracted venous infusion 5-fluorouracil in combination with subcutaneous interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer: a phase II study Br J Cancer 83 980 985
10. J Atzpodien H Kirchner U Rebmann, et al. 2006 Interleukin-2/interferon- alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) Br J Cancer 95 4 463 469
11. CM George NJ Vogelzang BI Rini, et al. 2002 A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma Ann Oncol 13 1 116 120
12. S Marsh 2005 Thymidylate synthase pharmacogenetics Invest New Drugs 23 533 537
13. SP Ackland SJ Clarke P Beale, et al. 2006 Thymidylate synthase inhibitors Update Cancer Ther 1 403 427
14. Y Mizutani H Wada O Yoshida, et al. 2003 Significance of thymidylate synthase activity in renal cell carcinoma Clin Cancer Res 9 1453 1460
15. N Horie H Aiba K Oguro, et al. 1995 Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5′-terminal regulatory region of the human gene for thymidylate synthase Cell Struct Funct 20 191 197
16. K Kawakami Y Ishida KD Danenberg, et al. 2002 Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity Jpn J Cancer Res 93 1221 1229
17. K Yoshioka 2002 KyPlot: a user-oriented tool for statistical data analysis and visualization Comput Stat 17 3 425 451
18. A Aguilera B Gómez-González 2008 Genome instability: a mechanistic view of its causes and consequences Nat Rev Genet 9 3 204 217
19. K Debacker B Winnepenninckx N Ben-Porat, et al. 2007 FRA18C: a new aphidicolin-inducible fragile site on chromosome 18q22, possibly associated with in vivo chromosome breakage J Med Genet 44 5 347 352
20. H Hirata H Matsuyama H Matsumoto, et al. 2005 Deletion mapping of 18q in conventional renal cell carcinoma Cancer Genet Cytogenet 163 101 105
21. JC Strefford I Stasevich Tm Lane, et al. 2005 A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma Cancer Genet Cytogenet 159 1 1 9
22. B Gunawan W Huber M Holtrup, et al. 2001 Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis Cancer Res 61 21 7731 7738
23. Y Tran K Benbatoul K Gorse, et al. 1998 Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast Oncogene 17 26 3499 3505
24. GG Wang JC Yao S Worah, et al. 2005 Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors Mod Pathol 18 8 1079 1087
25. K Uchida K Hayashi K Kawakami, et al. 2004 Loss of heterozygosity at the thymidylate synthase (TYMS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene Clin Cancer Res 10 433 439
26. JR Brody T Hucl E Gallmeier, et al. 2006 Genomic copy number changes affecting the thymidylate synthase (TS) gene in cancer: a model for patient classification to aid fluoropyrimidine therapy Cancer Res 66 9369 9373
27. A Ooyama Y Okayama T Takechi, et al. 2007 Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs Cancer Sci 98 4 577 583
28. TL Wang LA Diaz Jr K Romans, et al. 2004 Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients Proc Natl Acad Sci USA 101 9 3089 3094
29. J Climent JA Martinez-Climent D Blesa, et al. 2002 Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer Clin Cancer Res 8 12 3863 3869
30. L Rahman D Voeller M Rahman, et al. 2004 Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme Cancer Cell 5 4 341 351